Newsmeme!
Discover News you didn't know existed
Dear Dr. Donohue: I am a 15-year-old girl with less-than-perfect skin. My back, chest and face break out constantly. My mom suggested taking birth control pills, but I am hesitant. Fifteen seems too early. My mom was recently hospitalized for a blood clot, and the doctors said it could have been caused by the birth control pill. I am taking minocycline, but it doesn't always work. What should I ...
DEAR DR. DONOHUE: I am a 15-year-old girl with less-than-perfect skin. My back, chest and face break out constantly. My mom suggested taking birth control pills, but I am hesitant. Fifteen seems too early. My mom was recently hospitalized for a blood...
Background Hyperlipidemia has been suggested as a risk factor for stenosis of the aortic valve, but lipid-lowering studies have had conflicting results. Methods We conducted a randomized, double-blind trial involving ...
Background Five years of statin therapy lowers low-density lipoprotein (LDL) cholesterol substantially and, over a 5-year period, results in reductions in the incidence of cardiovascular events. The Simvastatin and Ezetimibe ...
Exercise warding off dementia, questions about the HPV vaccine, and more.
The link between cholesterol-lowering drug ezetimibe (marketed as Vytorin) and cancer is still not clear, wrote the editors of the leading medical journal New England Journal of Medicine (NEJM). More time is needed to assess the drug, they said, and in the meantime patients and doctors will have to live with the uncertainty.
Current experiences with one of the two CE Marked devices, the CoreValve ReValvingĀ® System for Percutaneous Aortic Valve Replacement (PAVR) have proved to be an overall success. This device consists of a porcine pericardial valve prosthesis mounted on a self-expanding Nitonol frame, which is delivered by means of an 18 French size (6mm) catheter.
Epidemiologists have cleared a class of cholesterol-lowering drug that had been implicated in a cancer scare.
Patients have been advised to carry on taking an anti-cholesterol treatment despite research that suggested it may be linked to higher cancer rates.
London, Sept 3 : Epidemiologists have cleared a class of cholesterol-lowering drug that had been implicated in a cancer scare.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |